Log off SitemapDisclaimer

Fewer adverse effects with Matrifen® transdermal pain relief patch

Matrifen® from Nycomed has fewer adverse effects and provides better pain relief for patients with severe chronic pain.

Fewer adverse effects with Matrifen® by NycomedMatrifen® has fewer adverse effects than other similar products and still provides efficient relief for patients with severe chronic pain.

>> More information on Matrifen® with fewer adverse effects

Fewer adverse effects are seen when using Matrifen than when using other similar products. The Matrifen transdermal patch can be used for chronic pain in osteoarthritis patients, pheumatoid arthritis patients, patients with respiratory depression, hypoventilation and cognitive impairment.

Fentanyl belongs to the group of opioids, and transdermal fentanyl has been shown to have fewer side effects compared to morphine tablets and other oral formulations of opiod analgesics.

About Nycomed
Nycomed is driving a new way of providing pharmaceutical products in Europe. Physicians are seeking new treatments that make a clear medical difference. But traditional pharmaceutical companies, with a single research department, are finding it harder to meet this need.

Nycomed, by contrast, can access the work of thousands of companies dedicated to research, and choose to make available the most innovative treatments.

Special features

To access the site you must confirm being a healthcare professional - use the link on the left side of this page

Mode of action video

An animation presenting the Matrifen® patch;
- Application
- Mode of action

Additional material

- Product details
- Pharmacokinetics
- Technical profile
Conversion tables for download 

- Oral morphine to Matrifen (100:1)
- Oral morphine to Matrifen (150:1)
- Potency table